New England Research & Management’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-26,400
| Closed | -$518K | – | 168 |
|
|
2022
Q2 | $518K | Sell |
26,400
-750
| -3% | -$14.7K | 0.3% | 107 |
|
|
2022
Q1 | $708K | Buy |
27,150
+2,600
| +11% | +$67.8K | 0.37% | 86 |
|
|
2021
Q4 | $697K | Buy |
24,550
+9,550
| +64% | +$271K | 0.34% | 89 |
|
|
2021
Q3 | $478K | Buy |
15,000
+1,150
| +8% | +$36.6K | 0.25% | 111 |
|
|
2021
Q2 | $480K | Sell |
13,850
-1,700
| -11% | -$58.9K | 0.25% | 118 |
|
|
2021
Q1 | $458K | Sell |
15,550
-550
| -3% | -$16.2K | 0.25% | 110 |
|
|
2020
Q4 | $494K | Sell |
16,100
-4,500
| -22% | -$138K | 0.31% | 100 |
|
|
2020
Q3 | $575K | Sell |
20,600
-11,600
| -36% | -$324K | 0.42% | 84 |
|
|
2020
Q2 | $691K | Sell |
32,200
-5,800
| -15% | -$124K | 0.49% | 76 |
|
|
2020
Q1 | $851K | Buy |
38,000
+2,900
| +8% | +$64.9K | 0.73% | 46 |
|
|
2019
Q4 | $1.03M | Buy |
35,100
+3,500
| +11% | +$103K | 0.69% | 51 |
|
|
2019
Q3 | $840K | Buy |
31,600
+22,100
| +233% | +$587K | 0.61% | 58 |
|
|
2019
Q2 | $321K | Buy |
+9,500
| New | +$321K | 0.22% | 132 |
|